BINAXNOW COVID-19 AG SELF TEST 2CT
Report
- Report Number
- 1221359-2024-00493
- Event Type
- Malfunction
- Date Received
- July 16, 2024
- Date of Event
- June 28, 2024
- Report Date
- August 26, 2024
- Manufacturer
- ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
- Product Code
- QKP
- UDI-DI
- 00811877011408
- PMA / PMN Number
- EUA210264
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- 003
Narratives
THE REMAINDER OF THE INVESTIGATION REMAINS IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION.
TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 220606 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 195-160/ LOT: 220606, TEST BASE PART NUMBER 195-430WJR/ LOT: 217803. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE NEGATIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 220606 SHOWED THAT THE COMPLAINT RATE IS (B)(4). ABBOTT DIAGNOSTICS SCARBOROUGH, INC. WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE.
THE CONSUMER REPORTED FALSE NEGATIVE RESULTS WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST KIT FOR FIVE (5) TESTS PERFORMED ON VARIOUS DATES. THIS MFR. REPORT ADDRESSES TEST ONE (1) OF FIVE (5). THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2024 ON A NASAL SAMPLE. REPEAT TESTING WAS PERFORMED ONCE MORE ON (B)(6) 2024, TWICE ON (B)(6) 2024, AND TWICE ON (B)(6) 2024 WHICH GENERATED FOUR (4) NEGATIVE RESULTS, AND ONE (1) POSITIVE RESULT ON (B)(6) 2024.THE CONSUMER INDICATED THEY WERE EXPERIENCING SYMPTOMS SUCH AS SORE THROAT AND RUNNY NOSE. ON (B)(6) 2024, THE CUSTOMER WAS PRESCRIBED PAXLOVID BY THEIR HEALTHCARE PROVIDER. THE CONSUMER CONFIRMED THERE WAS NO DEATH OR SERIOUS INJURY. NO ADDITIONAL INFORMATION, INCLUDING DELAY OR IMPACT IN THE PATIENT'S TREATMENT, WAS PROVIDED.
THE CONSUMER REPORTED FALSE NEGATIVE RESULTS WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST KIT FOR FIVE (5) TESTS PERFORMED ON VARIOUS DATES. THIS MFR. REPORT ADDRESSES TEST ONE (1) OF FIVE (5). THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2024 ON A NASAL SAMPLE. REPEAT TESTING WAS PERFORMED ONCE MORE ON (B)(6) 2024, TWICE ON(B)(6) 2024, AND TWICE ON (B)(6) 2024 WHICH GENERATED FOUR (4) NEGATIVE RESULTS, AND ONE (1) POSITIVE RESULT ON (B)(6) 2024.THE CONSUMER INDICATED THEY WERE EXPERIENCING SYMPTOMS SUCH AS SORE THROAT AND RUNNY NOSE. ON (B)(6) 2024, THE CUSTOMER WAS PRESCRIBED PAXLOVID BY THEIR HEALTHCARE PROVIDER. THE CONSUMER CONFIRMED THERE WAS NO DEATH OR SERIOUS INJURY. NO ADDITIONAL INFORMATION, INCLUDING DELAY OR IMPACT IN THE PATIENT'S TREATMENT, WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 739008 | BINAXNOW COVID-19 AG SELF TEST 2CT | CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. | QKP | ABBOTT DIAGNOSTICS SCARBOROUGH, INC. | 220606 | 00811877011408 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 82 YR | Female |